期刊文献+

伐昔洛韦片致血液透析患者脑病1例 被引量:2

Encephalopathy caused by valaciclovir tablets in a hemodialysis patient
下载PDF
导出
摘要 1例83岁女性患者,因“规律血液透析9年半,咳嗽、咳痰3d”入院。既往无癫痫等精神系统及神经系统病史,平时规律血透,1周3次。入院后因带状疱疹应用喷昔洛韦注射液(250mg,qd)及伐昔洛韦片(300mg,bid)。应用3d后患者突发意识不清,胡言乱语,肢体震颤,急检指标与前无特殊改变,头颅CT无明显异常。药师考虑为伐昔洛韦片导致的脑病症状,建议停用伐昔洛韦片,并加强血液透析,未停用喷昔洛韦等其他药物,医师采纳药师建议。加强血液透析4d后患者神志转清,肢体震颤消失,好转出院。 One 83-year-old female patient was hospitalized due to regular hemodialysis (3 times per week) for 9 and a half years, cough and expectoration for 3 days. The patient had no previous history of nervous system disease including epilepsy. Penciclovir injection (250 mg, qd) and valaciclovir tablets (300 mg, bid) were given to the patient for herpes zoster after admission. Three days later, the patient suddenly developed unconsciousness, babbing, limbs tremor. There was no special changes in the emergency lab tests indexes and head CT scan. Considering that the symptoms of encephalopathy was might caused by valaciclovir tablets, the pharmacist suggested stopping valaciclovir tablets and strengthening hemodialysis. After 4 days, the patient's consciousness was clear, limb tremors disappeared, and the patient was discharged after improvement.
作者 王冬雪 徐锋 侯继秋 WANG Dong-xue;XU Feng;HOU Ji-qiu(Department of Pharmacy, the Second Hospital of Jilin University, Changchun 130041,China;The Nephrosis Internal Medicine Department, the Second Hospital of Jilin University, Changchun 130041, China)
出处 《中国药物应用与监测》 CAS 2019年第3期181-182,共2页 Chinese Journal of Drug Application and Monitoring
基金 吉林省食品药品安全监测中心项目(2014)科技字(3309)号
关键词 伐昔洛韦 血液透析 脑病 药品不良反应 Valaciclovir Hemodialysis Encephalopathy Adverse drug reaction
  • 相关文献

参考文献4

二级参考文献27

  • 1周村建,王莉,郭在培,涂亚庭,卢念祖,郝飞.不同剂量和疗程伐昔洛韦治疗带状疱疹的多中心随机双盲对照研究[J].临床皮肤科杂志,2007,36(7):420-422. 被引量:19
  • 2国家食品药品监督管理局药品安全监督司.药品不良反应报告和监测工作手册[s].北京:,2005.
  • 3Beauchamp LM, Orr FG, De P, et al. Aminoacid ester pro- drugs of acyclovir [ J ]. Antiviral Chem Chemother, 1992, 3 (3) :57.
  • 4Bodsworth NJ, Crooks PJ, Borelli S, et al. Valaclovir versus acyclovir inpatient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial [ J ]. Geni- tourin Med, 1997,73 : 110.
  • 5Spruance SL, Tying SK, Degregorio B, et al. A Largescale , placebocontrolled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis [ J ] .'Arch Intern Med,1996, 156:1729.
  • 6Kitching AR, Fagg D, Hay NM, et al. Neurotoxicity associ- ated with acyclovir in end stage renal failure [ J ]. NZ Med J, 1997, 110(1043) : 167-169.
  • 7Rajah GR, Cobb JP,Reiss CK. Acyclovir induced corn a in the intensive care unit [ J ]. Anaesth 1 ntensive Care, 2000,28 ( 3 ) : 305-307.
  • 8Izzedine H, Mercadal L, Ayrnard G, et al. Neurotoxicity of valacyclovir in peritoneal dialysis a pharnacokinetic study [J]. Am JNephrol,2001, 21(2) : 162-164.
  • 9谭锦文.哌拉西林/他唑巴坦治疗吸人性肺炎的临床观察[J].中国医院感染学杂志,2012,22(12):2661.
  • 10游力,孟峰芳.伊七叶皂昔钠致急性肾功能衰竭1例[J].中国新药杂志,1999,8(9):627.

共引文献29

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部